Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sanjeev Mariathasan

Years Active: 2020-2021
Publications (10 Years): 2

Genentech Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genentech Inc Jan 1o 2002

United States

Principal Scientist :: Oncology Biomarker Development

Publications

Romain Banchereau, Ning Leng, Oliver A Zill, Ethan Sokol, Gengbo Liu, Dean Pavlick, Sophia Maund, Li-Fen Liu, Edward E Kadel, Nicole E Baldwin, Suchit Jhunjhunwala, Dorothee Nickles, Zoe June Assaf, Daniel Bower, Namrata Patil, Mark McCleland, David Shames, Luciana Molinero, Mahrukh A Huseni, Shomyseh Sanjabi, Craig Cummings, Ira Mellman, Sanjeev Mariathasan, Priti Hegde, Thomas Powles
Molecular determinants of response to PD-L1 blockade across tumor types. Nature communications 12 (1) (2021)
Kobe C Yuen, Li-Fen Liu, Vinita Gupta, Shravan Madireddi, Shilpa Keerthivasan, Congfen Li, Deepali Rishipathak, Patrick Williams, Edward E Kadel, Hartmut Koeppen, Ying-Jiun Chen, Zora Modrusan, Jane L Grogan, Romain Banchereau, Ning Leng, AnnChristine Thastrom, Xiadong Shen, Kenji Hashimoto, Darren Tayama, Michiel S van der Heijden, Jonathan E Rosenberg, David F McDermott, Thomas Powles, Priti S Hegde, Mahrukh A Huseni, Sanjeev Mariathasan
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nature medicine 26 (5) (2020)

Sanjeev Mariathasan.css-eqlu8i{font-size:small;padding-left:4px;}